Fundamental Analysis
76 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +149.0% | +1194.5% | 3 / 3 | +26.4% | +0.79 pp | +0.19 pp | +3.7% | 0.92 | 16.22 | 639 | +26,4% | 2,4 | +149,0% | 16.22 | 74.15 | −78,1% |
| Pts | 12 | 12 | 12 | 12 | 8 | 8 | 0 | 6 | 12 | |||||||
Valuation annotation:Price: 7.000 (close price on 2026-10-12)EPS (TTM): 431,5
Financial charts
1.Revenue & growth
VND bn639Q3/26
1.Revenue & growth
VND bn639Q3/26
2.Profit & growth
VND bn2,41Q3/26
3.Profit mix (Penman)
VND bn14,6Q3/26
4.Margins & cost structure
%3.7%Q3/26
5.Returns & cash cycle
% · days3.0%Q3/26
6.Earnings quality & cash
VND bn-43,2Q3/26
7.Asset structure
VND bn777Q3/26
8.Funding & debt health
VND bn · times777Q3/26
9.Revenue backlog
VND bn0,30Q3/26
10.Valuation
times · %16,2×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %82Q3/26
Adjusted EPS growth, latest quarter
149%
Average adjusted EPS growth, 3 quarters
12,9× higher
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26